{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:12:56Z","timestamp":1793679176276,"version":"4.5.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82572056, 82171788, 82371810"],"award-info":[{"award-number":["82572056, 82171788, 82371810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03752-7","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T11:04:23Z","timestamp":1769252663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dysregulation of YTHDF2 promotes the over expression of interferon beta in anti-MDA5 antibody-positive dermatomyositis"],"prefix":"10.1186","volume":"28","author":[{"given":"Mengxiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"3752_CR1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/art.41964","volume":"74","author":"M Casal-Dominguez","year":"2022","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Pak K, Huang W, Selva-O\u2019Callaghan A, Albayda J, et al. Performance of the 2017 European alliance of associations for rheumatology\/American college of rheumatology classification criteria for idiopathic inflammatory myopathies in patients with Myositis-Specific autoantibodies. Arthritis Rheumatol. 2022;74:508\u201317.","journal-title":"Arthritis Rheumatol"},{"key":"3752_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","volume":"20","author":"X Lu","year":"2024","unstructured":"Lu X, Peng Q, Wang G. Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress. Nat Rev Rheumatol. 2024;20:48\u201362.","journal-title":"Nat Rev Rheumatol"},{"key":"3752_CR3","doi-asserted-by":"crossref","unstructured":"He J, Liu Z, Cao Y, Zhang X, Yi C, Zhou Y, et al. Single-cell landscape of peripheral immune response in patients with anti-melanoma differentiation-associated gene 5 dermatomyositis. Rheumatology (Oxford); 2023.","DOI":"10.2139\/ssrn.4549223"},{"key":"3752_CR4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/annrheumdis-2017-212149","volume":"77","author":"Y Kochi","year":"2018","unstructured":"Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, et al. Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis. Ann Rheum Dis. 2018;77:602\u201311.","journal-title":"Ann Rheum Dis"},{"key":"3752_CR5","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/bjd.16917","volume":"180","author":"SH Zhang","year":"2019","unstructured":"Zhang SH, Zhao Y, Xie QB, Jiang Y, Wu YK, Yan B. Aberrant activation of the type I interferon system May contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis. Br J Dermatol. 2019;180:1090\u20138.","journal-title":"Br J Dermatol"},{"key":"3752_CR6","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1212\/WNL.0000000000008128","volume":"93","author":"I Pinal-Fernandez","year":"2019","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Plotz P, Miller FW, et al. Identification of distinctive interferon gene signatures in different types of myositis. Neurology. 2019;93:e1193\u2013204.","journal-title":"Neurology"},{"key":"3752_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/annrheumdis-2019-216599","volume":"79","author":"I Pinal-Fernandez","year":"2020","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Miller FW, Milisenda JC, et al. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis. Ann Rheum Dis. 2020;79:1234\u201342.","journal-title":"Ann Rheum Dis"},{"key":"3752_CR8","first-page":"28","volume":"165","author":"N Liu","year":"2015","unstructured":"Liu N, Pan T. RNA Epigenetics Transl Res. 2015;165:28\u201335.","journal-title":"RNA Epigenetics Transl Res"},{"key":"3752_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m\u2076A RNA methylation. Nat Rev Genet. 2014;15:293\u2013306.","journal-title":"Nat Rev Genet"},{"key":"3752_CR10","doi-asserted-by":"crossref","unstructured":"Geng Q, Cao X, Fan D, Wang Q, Wang X, Zhang M et al. Potential medicinal value of N6-methyladenosine in autoimmune diseases and tumours. Br J Pharmacol. 2025;182:4189\u2013200.","DOI":"10.1111\/bph.16030"},{"key":"3752_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-020-00872-8","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi Y, Shen H. Xie. m(6)A-binding proteins: the emerging crucial performers in epigenetics. J Hematol Oncol. 2020;13:35.","journal-title":"J Hematol Oncol"},{"key":"3752_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41576-022-00534-0","volume":"24","author":"K Boulias","year":"2023","unstructured":"Boulias K, Greer EL. Biological roles of adenine methylation in RNA. Nat Rev Genet. 2023;24:143\u201360.","journal-title":"Nat Rev Genet"},{"key":"3752_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12935-021-01807-0","volume":"21","author":"JY Wang","year":"2021","unstructured":"Wang JY, Lu AQ. The biological function of m6A reader YTHDF2 and its role in human disease. Cancer Cell Int. 2021;21:109.","journal-title":"Cancer Cell Int"},{"key":"3752_CR14","doi-asserted-by":"publisher","first-page":"102638","DOI":"10.1016\/j.redox.2023.102638","volume":"61","author":"L Hu","year":"2023","unstructured":"Hu L, Yu Y, Shen Y, Huang H, Lin D, Wang K, et al. Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages. Redox Biol. 2023;61:102638.","journal-title":"Redox Biol"},{"key":"3752_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12943-024-02097-6","volume":"23","author":"Z Yang","year":"2024","unstructured":"Yang Z, Wang X, Fu Y, Wu W, Hu Z, Lin Q, et al. YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8(+) T cell recruitment. Mol Cancer. 2024;23:186.","journal-title":"Mol Cancer"},{"key":"3752_CR16","doi-asserted-by":"publisher","first-page":"959388","DOI":"10.3389\/fmed.2022.959388","volume":"9","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Wu X, Deng C, Zhao L, Peng L, Zhou J, et al. The potential role of RNA N6-methyladenosine in primary Sj\u00f6gren\u2019s syndrome. Front Med (Lausanne). 2022;9:959388.","journal-title":"Front Med (Lausanne)"},{"key":"3752_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00281-017-0621-5","volume":"39","author":"C Ospelt","year":"2017","unstructured":"Ospelt C, Gay S. Klein. Epigenetics in the pathogenesis of RA. Semin Immunopathol. 2017;39:409\u201319.","journal-title":"Semin Immunopathol"},{"key":"3752_CR18","doi-asserted-by":"publisher","first-page":"1041284","DOI":"10.3389\/fimmu.2022.1041284","volume":"13","author":"Q Geng","year":"2022","unstructured":"Geng Q, Cao X, Fan D, Gu X, Zhang Q, Zhang M, et al. Diagnostic gene signatures and aberrant pathway activation based on m6A methylation regulators in rheumatoid arthritis. Front Immunol. 2022;13:1041284.","journal-title":"Front Immunol"},{"key":"3752_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrrheum.2015.14","volume":"11","author":"S Onuora","year":"2015","unstructured":"Onuora S. Epigenetics: demethylation of IFN-regulated genes in SLE neutrophils. Nat Rev Rheumatol. 2015;11:128.","journal-title":"Nat Rev Rheumatol"},{"key":"3752_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaut.2015.10.002","volume":"67","author":"AH Sawalha","year":"2016","unstructured":"Sawalha AH, Dozmorov MG. Epigenomic functional characterization of genetic susceptibility variants in systemic vasculitis. J Autoimmun. 2016;67:76\u201381.","journal-title":"J Autoimmun"},{"key":"3752_CR21","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, et al. 2017 European league against Rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017;69:2271\u201382.","journal-title":"Arthritis Rheumatol"},{"key":"3752_CR22","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nprot.2014.047","volume":"9","author":"D Su","year":"2014","unstructured":"Su D, Chan CT, Gu C, Lim KS, Chionh YH, McBee ME, et al. Quantitative analysis of ribonucleoside modifications in tRNA by HPLC-coupled mass spectrometry. Nat Protoc. 2014;9:828\u201341.","journal-title":"Nat Protoc"},{"key":"3752_CR23","doi-asserted-by":"publisher","first-page":"e22283","DOI":"10.1096\/fj.202200005RR","volume":"36","author":"Z Sun","year":"2022","unstructured":"Sun Z, Su Z, Zhou Z, Wang S, Wang Z, Tong X, et al. RNA demethylase ALKBH5 inhibits TGF-\u03b2-induced EMT by regulating TGF-\u03b2\/SMAD signaling in non-small cell lung cancer. Faseb J. 2022;36:e22283.","journal-title":"Faseb J"},{"key":"3752_CR24","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1093\/rheumatology\/kead001","volume":"62","author":"JGC Peeters","year":"2023","unstructured":"Peeters JGC, Boltjes A, Scholman RC, Vervoort SJ, Coffer PJ, Mokry M, et al. Epigenetic changes in inflammatory arthritis monocytes contribute to disease and can be targeted by JAK Inhibition. Rheumatology (Oxford). 2023;62:2887\u201397.","journal-title":"Rheumatology (Oxford)"},{"key":"3752_CR25","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/rheumatology\/kead597","volume":"63","author":"J He","year":"2024","unstructured":"He J, Liu Z, Cao Y, Zhang X, Yi C, Zhou Y, et al. Single-cell landscape of peripheral immune response in patients with anti-melanoma differentiation-associated gene 5 dermatomyositis. Rheumatol (Oxf). 2024;63:2284\u201394.","journal-title":"Rheumatol (Oxf)"},{"key":"3752_CR26","doi-asserted-by":"publisher","first-page":"1151695","DOI":"10.3389\/fimmu.2023.1151695","volume":"14","author":"J Qian","year":"2023","unstructured":"Qian J, Li R, Chen Z, Cao Z, Lu L, Fu Q. Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients. Front Immunol. 2023;14:1151695.","journal-title":"Front Immunol"},{"key":"3752_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41590-018-0275-z","volume":"20","author":"R Winkler","year":"2019","unstructured":"Winkler R, Gillis E, Lasman L, Safra M, Geula S, Soyris C, et al. m(6)A modification controls the innate immune response to infection by targeting type I interferons. Nat Immunol. 2019;20:173\u201382.","journal-title":"Nat Immunol"},{"key":"3752_CR28","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1002\/mgg3.1298","volume":"8","author":"Q Luo","year":"2020","unstructured":"Luo Q, Rao J, Zhang L, Fu B, Guo Y, Huang Z, et al. The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus. Mol Genet Genomic Med. 2020;8:e1298.","journal-title":"Mol Genet Genomic Med"},{"key":"3752_CR29","doi-asserted-by":"publisher","first-page":"102993","DOI":"10.1016\/j.jaut.2023.102993","volume":"135","author":"Z Lyu","year":"2023","unstructured":"Lyu Z, Huang B, Zhang J, Qian Q, Pu X, Cui N, et al. Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells. J Autoimmun. 2023;135:102993.","journal-title":"J Autoimmun"},{"key":"3752_CR30","doi-asserted-by":"publisher","first-page":"12626","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M, et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun. 2016;7:12626.","journal-title":"Nat Commun"},{"key":"3752_CR31","doi-asserted-by":"publisher","first-page":"11974","DOI":"10.1021\/jacs.8b05012","volume":"140","author":"S Rauch","year":"2018","unstructured":"Rauch S, He C. Dickinson. Targeted m(6)A reader proteins to study epitranscriptomic regulation of single RNAs. J Am Chem Soc. 2018;140:11974\u201381.","journal-title":"J Am Chem Soc"},{"key":"3752_CR32","doi-asserted-by":"publisher","first-page":"204062232210981","DOI":"10.1177\/20406223221098128","volume":"13","author":"Y Ding","year":"2022","unstructured":"Ding Y, Ge Y. Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome. Ther Adv Chronic Dis. 2022;13:20406223221098128.","journal-title":"Ther Adv Chronic Dis"},{"key":"3752_CR33","doi-asserted-by":"publisher","first-page":"5735279","DOI":"10.1155\/2020\/5735279","volume":"2020","author":"Q Luo","year":"2020","unstructured":"Luo Q, Gao Y, Zhang L, Rao J, Guo Y, Huang Z, et al. Decreased ALKBH5, FTO, and YTHDF2 in peripheral blood are as risk factors for rheumatoid arthritis. Biomed Res Int. 2020;2020:5735279.","journal-title":"Biomed Res Int"},{"key":"3752_CR34","doi-asserted-by":"publisher","first-page":"103334","DOI":"10.1016\/j.autrev.2023.103334","volume":"22","author":"M Gasparotto","year":"2023","unstructured":"Gasparotto M, Franco C, Zanatta E, Ghirardello A, Zen M, Iaccarino L, et al. The interferon in idiopathic inflammatory myopathies: different signatures and new therapeutic perspectives. A literature review. Autoimmun Rev. 2023;22:103334.","journal-title":"Autoimmun Rev"},{"key":"3752_CR35","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jid.2019.10.020","volume":"140","author":"C Cassius","year":"2020","unstructured":"Cassius C, Amode R, Delord M, Battistella M, Poirot J, How-Kit A, et al. MDA5(+) dermatomyositis is associated with stronger skin type I interferon transcriptomic signature with upregulation of IFN-\u03ba transcript. J Invest Dermatol. 2020;140:1276\u2013e97.","journal-title":"J Invest Dermatol"},{"key":"3752_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/rheumatology\/key386","volume":"58","author":"N Ono","year":"2019","unstructured":"Ono N, Kai K, Maruyama A, Sakai M, Sadanaga Y, Koarada S, et al. The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients. Rheumatology (Oxford). 2019;58:786\u201391.","journal-title":"Rheumatology (Oxford)"},{"key":"3752_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tim.2018.08.007","volume":"27","author":"AG Dias Junior","year":"2019","unstructured":"Dias Junior AG, Sampaio NG, Rehwinkel J. A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends Microbiol. 2019;27:75\u201385.","journal-title":"Trends Microbiol"},{"key":"3752_CR38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/1744666X.2021.1925541","volume":"17","author":"S Keeling","year":"2021","unstructured":"Keeling S, Maksymowych WP. JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials. Expert Rev Clin Immunol. 2021;17:701\u201315.","journal-title":"Expert Rev Clin Immunol"},{"key":"3752_CR39","doi-asserted-by":"crossref","unstructured":"Radu AF, Bungau SG. Manage Rheumatoid Arthritis: An Overview. Cells. 2021;10:2857.","DOI":"10.3390\/cells10112857"},{"key":"3752_CR40","doi-asserted-by":"publisher","first-page":"103276","DOI":"10.1016\/j.autrev.2023.103276","volume":"22","author":"M Benucci","year":"2023","unstructured":"Benucci M, Bernardini P, Coccia C, De Luca R, Levani J, Economou A, et al. JAK inhibitors and autoimmune rheumatic diseases. Autoimmun Rev. 2023;22:103276.","journal-title":"Autoimmun Rev"},{"key":"3752_CR41","doi-asserted-by":"publisher","first-page":"1693336","DOI":"10.3389\/fimmu.2025.1693336","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Pu S, Lian K, Li L. Jiang. m6A RNA modification in tumor-associated macrophages: emerging roles in cancer immunity. Front Immunol. 2025;16:1693336.","journal-title":"Front Immunol"},{"key":"3752_CR42","doi-asserted-by":"publisher","first-page":"tkad023","DOI":"10.1093\/burnst\/tkad023","volume":"11","author":"Z Zeng","year":"2023","unstructured":"Zeng Z, Lan Y, Zhang L, Chen Y, Gong Y, Zuo F, et al. The m6A reader YTHDF2 alleviates the inflammatory response by inhibiting IL-6R\/JAK2\/STAT1 pathway-mediated high-mobility group box-1 release. Burns Trauma. 2023;11:tkad023.","journal-title":"Burns Trauma"},{"key":"3752_CR43","doi-asserted-by":"publisher","first-page":"2419117","DOI":"10.1080\/08916934.2024.2419117","volume":"57","author":"H Zhang","year":"2024","unstructured":"Zhang H, Fan K, Zhang Z, Guo Y, Mo X. Genome-wide identification of cell type-specific susceptibility genes for juvenile dermatomyositis through the analysis of N(6)-methyladenosine-associated SNPs. Autoimmunity. 2024;57:2419117.","journal-title":"Autoimmunity"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03752-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03752-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03752-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:00:45Z","timestamp":1771326045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03752-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3752"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03752-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee of China-Japan Friendship Hospital with the ethical approval number 2022-KY-156. All participants in this study have submitted written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}